Hyper-CVAD is a chemotherapy regimen used to treat some forms of leukemia, high grade non-Hodgkin lymphoma, and lymphoblastic leukemia. It alternates two drug combinations over as many as eight cycles roughly three weeks apart: one course of fractionated cyclophosphamide, vincristine, doxorubicin, marketed as Adriamycin, and dexamethasone, alternating with a course of high dose methotrexate and cytarabine. Treatment is typically given in an inpatient hospital setting through a continuous venous access device.
Facts
Connections
Treats
Source Hyper-CVAD (Wikipedia)
Source Hyper-CVAD (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/Hyper-CVAD, lead sectionQuote, https://en.wikipedia.org/wiki/Hyper-CVAD, lead section
Hyper-CVAD is a chemotherapy regimen used to treat some forms of leukemia, high-grade non-Hodgkin lymphoma, and lymphoblastic leukemia.
Wikidata: Hyper-CVAD
Wikidata Q5957509, class allow-list match (w-wdresolver-0926)View the Source Hyper-CVAD (Wikipedia)
Treats: Leukemia, Lead: treats Leukemia
Hyper-CVAD is a chemotherapy regimen used to treat some forms of leukemia, high-grade non-Hodgkin lymphoma, and lymphoblastic leukemia.
Treats: Non-Hodgkin Lymphoma, Lead: treats Non-Hodgkin Lymphoma
Hyper-CVAD is a chemotherapy regimen used to treat some forms of leukemia, high-grade non-Hodgkin lymphoma, and lymphoblastic leukemia.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.